Outlook on the Specialty Enzymes Global Market to 2026 - Demand for Biocatalysts is Driving Growth

News provided by

Jun 01, 2021, 10:00 ET

DUBLIN, June 1, 2021 /PRNewswire/ -- The "Specialty Enzymes Market Based on Application, Source, Type and Geography - Global Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.

The Specialty Enzymes Market is anticipated to grow at the rate of 7.31% CAGR by 2026. The increasing elderly population will enhance the pharmaceutical, diagnostic enzyme demand, and considerable investments in biotech will further increase enzymes' demand. The demand for biocatalysts is also projected to intensify the market growth at a robust pace. Moreover, the drug and chemical manufacturers continue to discover biocatalysts as alternative production methods, which is likely to overcome escalating production costs.

However, the high costs incurred in adopting specialty enzymes for small and medium enterprises limit the specialty enzymes market growth. Specialty enzymes are biocatalysts and contemplated for accelerating various types of chemical reactions without going through self-changes. In various applications such as DNA manipulation, research, biotechnology, etc., these specialty enzymes are adopted. There are several different purposes of specialty enzymes in less quantity and significant applications. Pharmaceutical drug formulations based on specialty enzymes are used in chronic diseases such as cancer and AIDS treatment.

Specialty Enzymes Market based on Application

Pharmaceutical
Biotechnology R&D
Diagnostic

Specialty Enzymes Market based on Source

Microorganisms
Plants
Animals

Specialty Enzymes Market based on Type

Acylases
Hydratases
Humulin
Oxidase
Lyases
Restriction enzymes
Ligases
Polymerases & Nucleases
Others

Specialty Enzymes Market based on Geography

North America
Europe
Asia Pacific
Rest of the World

In the application market, the demand for specialty enzymes is growing due to the rising application of enzymes in pharmaceuticals. The adoption of specialty enzymes in pharmaceuticals is majorly in manufacturing drugs, disease diagnosis, or therapy. The growing integration of enzymes in therapies of few diseases such as cardiovascular, cancer, lysosomal storage disorders, pain, and controlling inflammation, among others, is also contributing to the segment growth.

In the specialty enzymes market segmentation as per the source, the microorganisms segment is projected to account for the market's highest share. These are the major source of specialty enzymes due to their exceptional features and other biochemical properties. Additionally, microbial enzymes are significant sources of raw materials for specific applications because of their varieties.

As per the type, the polymerases & nucleases segment is predicted to command the market. Polymerases & nucleases are deployed in specialty applications, such as research & biotechnology, diagnostics, pharmaceuticals, and biocatalysts. Polymerases & nucleases have been put together; hence, they function on nucleic acid polymers such as ribonucleic acid and deoxyribonucleic acid and are generally used in similar applications. This type of enzyme catalyzes the combination of deoxyribonucleic acid and ribonucleic acid polymers since they are essential for all nucleic acid processing, along with replication, repair, recombination, and transcription.

Based on geography, North America has a significant contribution to the market share. The significant contribution is attributed to the development of new and outstanding performing products and international industrialization. Moreover, the rising usage of enzymes in the pharmaceutical industry in this region also supports the growth of the market.

One of the current drifts that will advance grip in the global specialty enzymes market in the estimated period is increasing research and development savings. Worldwide researchers are increasing their attention towards many research and development activities that will augment the industry, including discovering and preparing enzymes out of fungi and microbes and the growth of next-generation enzymes that can be discarded over sectors only restricted to the diagnosis or pharmaceutical segments.

Key competitors profiled in the specialty enzymes market are Amano Enzymes, Dyadic International, Specialty Enzymes & Probiotics, Enzyme Development Corporation, Nagase & Co. Ltd, BBI Solutions, Advanced Enzymes, Sanofi, Biocatalysts, Enzyme Supplies, Amicogen, and Antozyme Biotech.

Furthermore, the specialty enzymes have a vital role in human life and cater to a broad range of essential body functions. Moreover, the inclination towards the usage of specialty enzymes to reduce the dependency on conventional enzymes has been observed in the past few years.

This report includes the market structure and the assessment of the segments and sub-segments of the specialty enzymes market.
The specialty enzymes market research also depicts the historical and future revenue of market segments.
This report further offers a geographical analysis to understand the market size around the world.
This study provides a thorough analysis of the key competitors' strategic framework to help the other players understand the market competition.

Key Topics Covered:

1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets

4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis

5. Application: Market Size & Analysis
5.1. Overview
5.2. Pharmaceutical
5.3. Biotechnology R&D
5.4. Diagnostic

6. Source: Market Size & Analysis
6.1. Overview
6.2. Microorganisms
6.3. Plants
6.4. Animals

7. Type: Market Size & Analysis
7.1. Overview
7.2. Acylases
7.3. Hydratases
7.4. Humulin
7.5. Oxidase
7.6. Lyases
7.7. Restriction enzymes
7.8. Ligases
7.9. Polymerases & Nucleases
7.10. Others

8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World

9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution

10. Vendor Profiles
10.1. Amano Enzymes
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Dyadic International
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Specialty Enzymes & Probiotics
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Enzyme Development Corporation
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Nagase & Co. Ltd
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. BBI Solutions
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Advanced Enzymes
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Sanofi
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Biocatalysts
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Enzyme Supplies
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy

11. Companies to Watch
11.1. Amicogen
11.1.1. Overview
11.1.2. Products & Services
11.1.3. Business Strategy
11.2. Antozyme Biotech
11.2.1. Overview
11.2.2. Products & Services
11.2.3. Business Strategy

12. Analyst Opinion

13. Annexure